Evidence map›Paper›PMID 34257600›Full record

ArticlePathology oncology research : POR2021

Clinicopathological Features, Tumor Mutational Burden, and Tumour-Infiltrating Lymphocyte Interplay in

Shiro Uchida, Takaaki Kojima, Takashi Sugino

Open access · goldAbstract read
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Insights into E-Cadherin Impairment inInternational journal of molecular sciences · 2024
    Article
  4. Current issues in molecular biology · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shiro UchidaDivision of Diagnostic Pathology, Kikuna Memorial Hospital, Yokohama, Japan.
Takaaki KojimaGraduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Takashi SuginoDivision of Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
Shizuoka Cancer Center · JPNagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent evidence suggests that somatic mutations in

Indexed as

MutationAdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsCarcinoma, LobularCD8-Positive T-LymphocytesComputer SimulationErb-b2 Receptor Tyrosine KinasesFemaleFollow-Up StudiesHumansLymphocytes, Tumor-InfiltratingMiddle AgedNeoplasm InvasivenessBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesBioinformactics analysisBreast cancerErbB2 mutationtumor mutational burdentumour-infiltrating lymphocytes

Identifiers

PMID34257600
PMCPMC8262144
OpenAlexW3145955706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.